1-Boc-4-(2-fluorophenyl)-4-carboxypiperidine

Catalog No.: 
ACKSUW097
CAS No.: 
954125-26-9
Molecular Formula: 
C17H22FNO4
Molecular Weight: 
323.36
1-Boc-4-(2-fluorophenyl)-4-carboxypiperidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$176.00InquiryInquiry
250mg98%$254.00InquiryInquiry
1g98%$645.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Boc-4-(2-fluorophenyl)-4-carboxypiperidine
IUPAC Name1-Boc-4-(2-fluorophenyl)-4-carboxypiperidine
MDL No.MFCD11506653
Molecular FormulaC17H22FNO4
Molecular Weight323.36
SMILESO=C(C1(C2=CC=CC=C2F)CCN(C(OC(C)(C)C)=O)CC1)O
InChI KeyWQZKZFIHTLSMTL-UHFFFAOYSA-N
Synonym1-BOC-4-(2-FLUOROPHENYL)-4-PIPERIDINEDICARBOXYLIC ACID;N-BOC-4-(O-FLUOROPHENYL)-4-PIPERIDINECARBOXYLIC ACID;1-Boc-4-(2-fluorophenyl)-4-carboxypiperidine;1,4-Piperidinedicarboxylic acid, 4-(2-fluorophenyl)-, 1-(1,1-dimethylethyl) ester
CAS No.954125-26-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACKSUW097 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKSUW097 route product structure diagram
    ACKSUW097954125-26-9
Inquiry

2. ACKSUW097 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKSUW097 route product structure diagram
    ACKSUW097954125-26-9
Inquiry

3. ACKSUW097 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKSUW097 route product structure diagram
    ACKSUW097954125-26-9
Inquiry

Comments (0)